Currently accepted at: Journal of Participatory Medicine
Date Submitted: Aug 27, 2026
Open Peer Review Period: Oct 24, 2026 - Dec 19, 2026
Date Accepted: Nov 19, 2026
(currently open for review)
This paper has been accepted and is currently in production.
It will appear shortly on 10.2196/110651
The final accepted version (not copyedited yet) is in this tab.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Patient-Led Multi-System Biomarker Tracking in Long COVID Mapping Vascular, Immune, and Neurological Markers Over Three Years in a 60-Year-Old Male with Post-Acute Sequelae of SARS-CoV-2 (PASC): A Viewpoint
ABSTRACT
Long COVID / post-acute sequelae of SARS-CoV-2 infection (PASC) develops in at least 10% of acute SARS-CoV-2 infections and is estimated to affect more than 65 million people worldwide [1]. The condition currently lacks accepted diagnostic biomarkers, effective therapeutic options, and, for many patients, any meaningful clinical support. This Viewpoint describes the methodology and utility of a single patient systematically tracking multi-system biomarkers including vascular, immune, and neurological biomarkers, over approximately three years to map his own condition, and reflects on what longitudinal, patient-generated data can and cannot reveal about an individual disease course.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.